Martijn Kleijwegt

Directeur/Membre du Conseil chez OCULIS HOLDING AG Fortune : 7 M $ au 30/06/2026

Profil

Martijn Kleijwegt is the founder of Life Sciences Partners BV (1998) as Managing Partner and EQT Life Sciences Group BV (1998) as Partner.
Current jobs include Managing Director at Life Sciences Partners II BV, Director at AM-Pharma BV, Director at The European Venture Capital Association, Director at Arvelle Therapeutics International GmbH (2019), Director at Pharvaris GmbH (2016), Independent Director at Oculis Holding AG (2023), Director at AM-Pharma Holding BV, Director at ViCentra BV, Director at VICO THERAPEUTICS.
INTERNATIONAL BV, Director at Avidicure Holding BV, and Director at Pantera NV.
Former jobs include Chairman at European Biotech Acquisition Corp.
(2021-2023), Director at CelMed BioSciences, Inc., Non-Executive Director at ISTO Technologies, Inc., Director at Intrexon ActoBiotics NV, Director at Movetis NV, Non-Executive Director at Asoyia, Inc., Director at OxThera AB, Non-Executive Director at Natil Technologies Ltd., Independent Director at Strategic Partners A (2017-2021), Director at Eloxx Pharmaceuticals Ltd., Managing Director at Lenildis Holding BV, Non-Executive Director at Pharvaris NV (2016-2021), Independent Director at Eloxx Pharmaceuticals, Inc. (2017-2021), General Partner at Euroventures Benelux I BV, Member-Supervisory Board at QIAGEN NV, Member-Supervisory Board at Crucell NV, Member-Supervisory Board at Rhein Biotech NV, Member-Supervisory Board at Kiadis Pharma BV (2006-2015), Member-Supervisory Board at Prosensa Holding NV, Partner at Euroventures Ukraine Fund II LP, Member-Supervisory Board at EyeSense AG, and Member-Supervisory Board at Kiadis Pharma NV.
Education includes an undergraduate degree from the University of Amsterdam (1983) and a graduate degree from the University of Amsterdam.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
OCULIS HOLDING AG 0,82 %	31/12/2025	470 969 ( 0,82 % )	7 M $	30/06/2026

Postes actifs de Martijn Kleijwegt

Sociétés	Poste	Début
OCULIS HOLDING AG	Directeur/Membre du Conseil	03/03/2023
LSP Management Group BV	Private Equity Investor	11/05/2009
AM-Pharma BV	Directeur/Membre du Conseil	-
Arvelle Therapeutics International GmbH	Directeur/Membre du Conseil	01/01/2019
Pharvaris GmbH	Directeur/Membre du Conseil	01/04/2016
VICO THERAPEUTICS INTERNATIONAL BV	Directeur/Membre du Conseil	-
AM-Pharma Holding BV	Directeur/Membre du Conseil	-
ViCentra BV	Directeur/Membre du Conseil	-
The European Venture Capital Association	Directeur/Membre du Conseil	-

Anciens postes connus de Martijn Kleijwegt

Sociétés	Poste	Fin
░░░░ ░░░░	░░░░░░░░░░	░░░░░░░░░░
░░░░ ░░░░░░░░ ░░░░░░░░ ░░	░░░░░░░░░ ░░░░░░░░░	░░░░░░░░░░
░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░ ░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░